EKSO
Price
$5.05
Change
+$0.36 (+7.68%)
Updated
Sep 26 closing price
Capitalization
13.2M
MBOT
Price
$3.22
Change
-$0.07 (-2.13%)
Updated
Sep 26 closing price
Capitalization
170M
41 days until earnings call
Interact to see
Advertisement

EKSO vs MBOT

Header iconEKSO vs MBOT Comparison
Open Charts EKSO vs MBOTBanner chart's image
Ekso Bionics Holdings
Price$5.05
Change+$0.36 (+7.68%)
Volume$96.19K
Capitalization13.2M
Microbot Medical
Price$3.22
Change-$0.07 (-2.13%)
Volume$2.28M
Capitalization170M
EKSO vs MBOT Comparison Chart in %
Loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EKSO vs. MBOT commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSO is a Buy and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (EKSO: $5.05 vs. MBOT: $3.22)
Brand notoriety: EKSO and MBOT are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EKSO: 115% vs. MBOT: 48%
Market capitalization -- EKSO: $13.2M vs. MBOT: $170M
EKSO [@Pharmaceuticals: Other] is valued at $13.2M. MBOT’s [@Pharmaceuticals: Other] market capitalization is $170M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKSO’s FA Score shows that 0 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • EKSO’s FA Score: 0 green, 5 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, EKSO is a better buy in the long-term than MBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKSO’s TA Score shows that 6 TA indicator(s) are bullish while MBOT’s TA Score has 3 bullish TA indicator(s).

  • EKSO’s TA Score: 6 bullish, 4 bearish.
  • MBOT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EKSO is a better buy in the short-term than MBOT.

Price Growth

EKSO (@Pharmaceuticals: Other) experienced а +14.37% price change this week, while MBOT (@Pharmaceuticals: Other) price change was +0.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

MBOT is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($170M) has a higher market cap than EKSO($13.2M). MBOT YTD gains are higher at: 187.500 vs. EKSO (-44.754). EKSO has higher annual earnings (EBITDA): -9.25M vs. MBOT (-13.4M). MBOT has more cash in the bank: 32.7M vs. EKSO (5.24M). MBOT has less debt than EKSO: MBOT (149K) vs EKSO (5.39M). EKSO has higher revenues than MBOT: EKSO (14.7M) vs MBOT (0).
EKSOMBOTEKSO / MBOT
Capitalization13.2M170M8%
EBITDA-9.25M-13.4M69%
Gain YTD-44.754187.500-24%
P/E RatioN/AN/A-
Revenue14.7M0-
Total Cash5.24M32.7M16%
Total Debt5.39M149K3,618%
FUNDAMENTALS RATINGS
EKSO vs MBOT: Fundamental Ratings
EKSO
MBOT
OUTLOOK RATING
1..100
2374
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
5036
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKSO's Valuation (45) in the Medical Specialties industry is in the same range as MBOT (57) in the Biotechnology industry. This means that EKSO’s stock grew similarly to MBOT’s over the last 12 months.

EKSO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MBOT (100) in the Biotechnology industry. This means that EKSO’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's SMR Rating (98) in the Biotechnology industry is in the same range as EKSO (99) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to EKSO’s over the last 12 months.

MBOT's Price Growth Rating (36) in the Biotechnology industry is in the same range as EKSO (50) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to EKSO’s over the last 12 months.

MBOT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EKSO (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to EKSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKSOMBOT
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLLNY16.720.28
+1.70%
Cellnex Telecom SA
BBBK43.10N/A
N/A
Baker Boyer Bancorp
BDVSF14.05N/A
N/A
Bidvest Group Ltd.
BZTAF10.46N/A
N/A
Boozt AB
XXMMF0.10N/A
N/A
XIMEN MINING CORP

EKSO and

Correlation & Price change

A.I.dvisor tells us that EKSO and MBOT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
+7.78%
MBOT - EKSO
25%
Poorly correlated
-2.13%
MYO - EKSO
25%
Poorly correlated
+2.32%
RVP - EKSO
24%
Poorly correlated
+0.74%
NMTC - EKSO
24%
Poorly correlated
+2.22%
PAVM - EKSO
23%
Poorly correlated
-1.26%
More

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with POAI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then POAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
-2.13%
POAI - MBOT
42%
Loosely correlated
-18.44%
RCEL - MBOT
34%
Loosely correlated
-2.44%
BNGO - MBOT
32%
Poorly correlated
-2.92%
AIMD - MBOT
32%
Poorly correlated
-0.85%
NNOX - MBOT
30%
Poorly correlated
-1.33%
More